Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

What is Monogastric Digestion?

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.

Bacterial Flora of the Large Intestine

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026

Same author

[Updated S3 guideline on ulcerative colitis].

Zeitschrift fur Gastroenterologie·2026

Same author

Impact of an antimicrobial stewardship intervention on carbapenem use in children with cancer.

Infection·2026

Same author

[Appendectomy as a disease-modifying therapy in ulcerative colitis?]

Zeitschrift fur Gastroenterologie·2026

Same author

[Therapy-refractory hepatic encephalopathy or acquired hepato-cerebral degeneration - a challenging differential diagnosis].

Zeitschrift fur Gastroenterologie·2026

Same author

When Behçet Mimics Crohn's disease: A Diagnostic Challenge.

Zeitschrift fur Gastroenterologie·2026

Same journal

The Prevalence of Hospitalized Cases of Necrotizing Fasciitis: Anatomical Distribution, Amputations, and In-Hospital Mortality, 2019-2024.

Deutsches Arzteblatt international·2026

Same journal

Subclinical Atrial Fibrillation: Detection, Stroke Risk, and Treatment.

Deutsches Arzteblatt international·2026

Same journal

Fewer Premature Births After Assisted Reproduction.

Deutsches Arzteblatt international·2026

Same journal

Femoral Artery Pseudoaneurysm Due to Stent Fracture in PAOD.

Deutsches Arzteblatt international·2026

Same journal

Pain-Adapted Full Weight-bearing After Ankle Fracture Surgery: A Multicenter, Pragmatic, Single-armed Prospective Study.

Deutsches Arzteblatt international·2026

Same journal

Popliteal Artery Entrapment Syndrome.

Deutsches Arzteblatt international·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 29, 2025

Murine Fecal Isolation and Microbiota Transplantation

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

Fecal Microbiota Transfer.

Andreas Stallmach¹, Arndt Steube, Philip Grunert

¹Department of Internal Medicine IV (Gastroenterology, Hepatology, Infectious Diseases), Jena University Hospital, Jena, Germany; University Pharmacy, Jena University Hospital, Jena, Germany; University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Germany; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.

Deutsches Arzteblatt International

|February 8, 2020

Summary

This summary is machine-generated.

Fecal microbiota transfer (FMT) is highly effective for recurrent Clostridioides difficile infection (rCDI). Encapsulated, frozen microbiota offers a standardized and safe treatment option for patients with rCDI.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Related Experiment Videos

Last Updated: Dec 29, 2025

Murine Fecal Isolation and Microbiota Transplantation

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Area of Science:

Microbiology
Gastroenterology
Infectious Diseases

Background:

Fecal microbiota transfer (FMT) is increasingly utilized globally for treating recurrent Clostridioides difficile infection (rCDI).
FMT is performed for research and individual patient treatment outside clinical trials.
Lack of standardized protocols for donor screening and fecal transfer methods poses potential risks.

Purpose of the Study:

To review the efficacy and safety of FMT for rCDI.
To establish best practices for FMT procedures.
To identify optimal methods for fecal microbiota administration.

Main Methods:

Selective literature search including consensus conference reports.
Review of studies on donor screening, FMT methods, and patient outcomes.
Analysis of data on efficacy and adverse events.

Main Results:

FMT is the preferred treatment for rCDI due to high efficacy.
FMT is generally safe, even in immunocompromised patients, with proper donor screening.
Oral ingestion of frozen, encapsulated microbiota is as effective as other delivery methods for rCDI.

Conclusions:

Encapsulated fecal microbiome (FM) stored at -20°C is the preferred method due to standardization and quality control.
Patients with rCDI should receive FMT via oral capsules.
Research is ongoing to identify active components of FM and explore recombinant production.